Boyd Peter E. (CIK 1739816) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-07). Recent activity: Sell AQST (56,778 shares), Buy AQST (80,000 shares), Sell AQST (29,814 shares), Buy AQST (20,000 shares), Sell AQST (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Sell | 56,778 | $237,332 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Buy | 80,000 | $0 |
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Sell | 29,814 | $124,324 |
| 2025-12-05 | Aquestive Therapeutics, Inc. (AQST) | Chief People Officer | Buy | 20,000 | $0 |
| 2025-10-17 | Aquestive Therapeutics, Inc. (AQST) | See Remarks | Sell | 10,000 | $70,000 |
| 2025-09-29 | Aquestive Therapeutics, Inc. (AQST) | See Remarks | Sell | 10,000 | $63,000 |
| 2025-09-08 | Aquestive Therapeutics, Inc. (AQST) | See Remarks | Sell | 15,000 | $79,500 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | See Remark | Buy | 80,000 | $0 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | See Remark | Sell | 6,624 | $17,554 |
| 2025-03-11 | Aquestive Therapeutics, Inc. (AQST) | See Remark | Sell | 7,681 | $20,355 |
Source: SEC Form 4 filings · as of 2026-05-07